Digitalni repozitorij raziskovalnih organizacij Slovenije

Izpis gradiva
A+ | A- | SLO | ENG

Naslov:Allergies and COVID-19 vaccines : an ENDA/EAACI position paper
Avtorji:Barbaud, Annick (Avtor)
Garvey, Lene Heise (Avtor)
Arcolaci, Alessandra (Avtor)
Brockow, Knut (Avtor)
Mori, Francesca (Avtor)
Mayorga, Cristobalina (Avtor)
Jošt, Maja (Avtor)
Košnik, Mitja (Avtor)
Zidarn, Mihaela (Avtor)
Torres, Maria J (Avtor)
Jezik:Angleški jezik
Tipologija:1.01 - Izvirni znanstveni članek
Organizacija:Logo UKPBAG - Univerzitetna klinika za pljučne bolezni in alergijo Golnik
Povzetek:Anaphylaxis, which is rare, has been reported after COVID 19 vaccination, but its management is not standardized. Method. Members of the European Network for Drug Allergy and the European Academy of Allergy and Clinical Immunology interested in drug allergy participated in an online questionnaire on pre-vaccination screening and management of allergic reactions to COVID-19 vaccines, and literature was analysed. Results. No death due to anaphylaxis to COVID-19 vaccines has been confirmed in scientific literature. Potential allergens, polyethylene glycol (PEG), polysorbate and tromethamine, are excipients. The authors propose allergy evaluation of persons with the following histories: 1- anaphylaxis to injectable drug or vaccine containing PEG or derivatives; 2- anaphylaxis to oral/topical PEG containing products; 3-recurrent anaphylaxis of unknown cause; 4-suspected or confirmed allergy to any mRNA vaccine, 5-confirmed allergy to PEG or derivatives. We recommend a prick-to-prick skin test with the left over solution in the suspected vaccine vial to avoid waste. Prick test panel should include PEG 4000 or 3500, PEG 2000 and polysorbate 80. The value of in vitro test is arguable. Conclusions. These recommendations will lead to a better knowledge of the management and mechanisms involved in anaphylaxis to COVID-19 vaccines and enable more people with history of allergy to be vaccinated.
Ključne besede:SARS-CoV-2, COVID-19, COVID-19 vaccines, allergens, anapylaxis, drug hypersensitivity
Leto izida:2022
Založnik:Wiley
Izvor:VelikaBritanija
UDK:616-097
ISSN pri članku:1398-9995
COBISS_ID:96566531 Povezava se odpre v novem oknu
DOI:10.1111/all.15241 Povezava se odpre v novem oknu
Opombe:Nasl. z nasl. zaslona; Soavtorji iz Slovenije: Maja Jošt, Mitja Košnik, Mihaela Zidarn; Opis vira z dne 7. 2. 2022;
Število ogledov:213
Število prenosov:54
Datoteke:URL URL - Izvorni URL, za dostop obiščite https://onlinelibrary.wiley.com/doi/epdf/10.1111/all.15241
 
Nadgradivo:Allergy
Blackwell
 
Metapodatki:XML RDF-CHPDL DC-XML DC-RDF
:
  
Postavite miškin kazalec na naslov za izpis povzetka. Klik na naslov izpiše podrobnosti ali sproži prenos.


Nazaj